Psychological profile of individuals presenting with chronic cough by Hulme, Katrin et al.
Citation: Hulme, Katrin, Deary, Vincent, Dogan, Sian and Parker, Sean (2017) Psychological 
profile of individuals presenting with chronic cough. ERJ Open Research, 3 (1). 00099. ISSN 
2312-0541 
Published by: European Respiratory Society
URL:  https://doi.org/10.1183/23120541.00099-2016 
<https://doi.org/10.1183/23120541.00099-2016>
This  version  was  downloaded  from  Northumbria  Research  Link: 
http://nrl.northumbria.ac.uk/30554/
Northumbria University has developed Northumbria Research Link (NRL) to enable users to 
access the University’s research output. Copyright ©  and moral rights for items on NRL are 
retained by the individual author(s) and/or other copyright owners.  Single copies of full items 
can be reproduced,  displayed or  performed,  and given to third parties in  any format  or 
medium for personal research or study, educational, or not-for-profit purposes without prior 
permission or charge, provided the authors, title and full bibliographic details are given, as 
well  as a hyperlink and/or URL to the original metadata page.  The content must  not  be 
changed in any way. Full  items must not be sold commercially in any format or medium 
without  formal  permission  of  the  copyright  holder.   The  full  policy  is  available  online: 
http://nrl.northumbria.ac.uk/policies.html
This document may differ from the final, published version of the research and has been 
made available online in accordance with publisher policies. To read and/or cite from the 
published version of the research, please visit the publisher’s website (a subscription may be 
required.)
Psychological profile of individuals
presenting with chronic cough
Katrin Hulme1,2,3, Vincent Deary4, Sian Dogan1 and Sean M. Parker1
Affiliations: 1Respiratory Medicine, North Tyneside Hospital, Northumbria Healthcare NHS Foundation Trust,
North Shields, UK. 2Health Psychology, Guy’s Hospital, King’s College London, London, UK. 3Health Psychology,
Staffordshire University, Stoke-on-Trent, UK. 4Psychology Dept, Northumbria University, Newcastle, UK.
Correspondence: Sean Parker, Consultant Respiratory Physician, Department of Respiratory Medicine,
Northumbria Healthcare NHSFT, North Tyneside General Hospital, Rake Lane, North Shields NE29 8NH, UK.
E-mail: sean.parker@nhct.nhs.uk
ABSTRACT Chronic refractory cough (CRC) is a common problem in respiratory clinics. Adverse effects
on quality of life are documented in the literature, but relatively little is known about the underlying
psychological factors in this patient population. We aimed to investigate the association of psychological
factors with chronic cough, comparing CRC to explained cough and non-cough groups.
67 patients attending a specialist cough clinic (CRC, n=25; explained cough, n=42) and 22 non-cough
individuals participated. All participants completed the Hospital Anxiety & Depression Scale, Big Five
Inventory (Personality), Chalder Fatigue Scale and Patient Health Questionnaire-15. Cough patients also
completed the Illness Perception Questionnaire-Revised. Appropriate statistical analyses were used to
compare participant groups.
Chronic refractory coughers displayed significantly higher levels of anxiety, depression, fatigue and somatic
physical symptoms than non-cough participants. Compared to explained coughers, there were higher
depression and fatigue scores and significantly more negative illness representations (specifically, strong beliefs
regarding negative consequences, lower illness coherence and higher emotional representations). “Explained”
coughers reported significantly increased fatigue and somatic symptoms in comparison to non-coughers.
The prevalence of fatigue, low mood, negative illness beliefs and increased physical symptom reporting
should be considered in consultations and in developing novel interventions for CRC patients.
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Introduction
Most patients who present with a persistent cough find the symptom resolves either naturally with time or
after a series of empirical treatment trials [1]. However, a significant number of patients (12–46%) have a
treatment-resistant, chronic refractory cough (CRC) with no evident cause [2].
Regardless of cause, a cough can disrupt various aspects of everyday life, such as sleep, social activities and
communication [3, 4]. A questionnaire study concluded that chronic coughers have increased levels of
emotional distress compared to a healthy population, although there was no non-cough comparison group [5].
There was no significant difference between explained and unexplained apart from state anxiety. A similar
study confirmed a higher than expected prevalence of depression in chronic cough, but did not distinguish
between refractory and explained coughers [6]. Improvements in cough symptoms after treatment correlated
with depression scores, possibly implying a causal link between cough impact on quality of life and
psychological wellbeing [10].
Research has shown that the cough reflex is more than a simple, protective reflex; it can be modulated
by attentional focus [7] and harmful information processing [8], as well as be voluntarily supressed or
modified [9]. Furthermore, functional magnetic resonance imaging (MRI) studies have mapped “urge to
cough” and cough suppression onto higher-order brain regions [10]. This evidence suggests a role for
higher-order, psychological processes in cough, highlighting a possible alternative avenue for cough treatment.
However, although current evidence for non-pharmacological treatment suggests it can be effective [11, 12],
the mechanisms of action are unclear. Increasing our understanding of the factors associated with the
condition is not only important for its own sake, but also to inform high-quality systematic intervention
development in line with the Medical Research Council guidelines for complex intervention development [13].
Psychosocial factors implicated in the onset or maintenance of other persistent physical symptoms have
the potential to contribute to our understanding of CRC. Personality variables, specifically neuroticism,
have been associated with a number of physical and mental health markers, both phenotypically and
genetically [14], including other so-called medically unexplained symptoms (MUSs) [15]. Although
neuroticism is of particular interest given the psychomorbidity findings reported previously [5, 6], all
personality dimensions are worth investigating.
Somatic symptoms often cluster and overlap. For example, irritable bowel syndrome (IBS) patients often
report lower back pain, muscle pain, difficulty concentrating, disturbed sleep and joint problems, symptoms
more commonly associated with chronic fatigue syndrome (CFS). Conversely, CFS patients often suffer
from the gastrointestinal symptoms associated with IBS [16]. The association of IBS symptoms and chronic
cough has also been noted [17], so investigating the presence of other somatic symptoms is warranted.
Fatigue has been measured in the cough literature but only as a subscale of a quality-of-life dimension.
Terms such as “exhaustion” and “sleep disturbance” appear in the cough literature [3, 4]. However, we are
not aware of research using a specific scale to quantify fatigue. Given the potentially detrimental impact of
fatigue on everyday functioning and coping [18], if it is prevalent then it should be considered during
intervention development.
Illness perceptions are an individual’s cognitive representation of their illness: its causes, associated symptoms,
consequences, timeline, controllability, emotional impact and conceptual coherence [19]. These beliefs guide
how the person understands and manages their illness. For example, negative consequence beliefs (adverse
impact of the condition), reduced illness coherence (an individual’s understanding of the illness) and
heightened emotional representations (an individual’s emotional reactions to the health condition) have been
shown to predict reduced quality of life in IBS [20, 21]. These factors may also be salient for CRC.
The aim of this exploratory study is to investigate psychological factors associated with chronic cough.
Specifically, we hypothesise that compared to explained coughers and non-cough participants, CRC
patients will have higher levels of negative affectivity, fatigue and negative illness perceptions.
Methods
Design
A cross-sectional questionnaire survey design was employed. Differential statistical analyses established
whether associations existed between the constructs and chronic cough, and investigated any differences
among the three groups.
Participants
Participants were consecutively recruited from a secondary-care specialist cough clinic at North Tyneside
Hospital between September 2014 and February 2015. Participating patients were also asked to take a
questionnaire bundle for a “non-cough” friend to complete; this was our healthy, non-cough comparison
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group. Inclusion criteria for clinic patients were: ⩾18 years old and chronic cough (>8 weeks, either
“refractory” or “explained”). For the non-cough participants, the inclusion criteria were: ⩾18 years old, no
chronic cough and not currently attending hospital appointments. Exclusion criteria were: unable to give
informed consent, serious coexistent psychiatric disorder and coexistent illness. Explained coughers were
defined as those who had a medical diagnosis to explain why they were coughing (for instance asthma,
chronic obstructive pulmonary disease (COPD) or interstitial lung disease) on the basis of clinical
assessment and response, in some cases, to treatment. Refractory coughers were those patients with no
objective pulmonary pathology who had not responded to trials of treatment. Patients were assigned to
these groups retrospectively following a review of the medical notes by the investigators.
Questionnaires
The following five validated questionnaires were utilised to measure their respective constructs: the Big
Five Inventory (BFI), the Chalder Fatigue Scale, the Patient Health Questionnaire-15 (PHQ-15), the
Hospital Anxiety and Depression Scale (HADS) and the Illness Perception Questionnaire-Revised (IPQ-R).
Big Five Inventory
The BFI is a 44-item inventory measuring the “Big Five” personality dimensions: openness,
conscientiousness, extraversion, agreeableness and neuroticism. Statements are rated using a 5-point Likert
scale: 1, “Disagree strongly” to 5, “Agree strongly”. This measure has good internal reliability (mean subscale
Cronbach’s α=0.83) [22].
Chalder Fatigue Scale
11 items are scored on a four-point scale from “less than usual (0)” to “much more than usual (3)”. The
higher the summed score, the more fatigued the individual. This measure has been validated in a
community sample (mean=14.2) and has high internal reliability; Cronbach’s α=0.92 [23].
Patient Health Questionnaire-15
15 items address somatic, physical symptoms in the past 4 weeks. Each response is rated on a 3-point
Likert scale from “not bothered at all (0)” to “bothered a lot (2)”. Scores are summed and higher scores
represent increased somatic symptom severity. Cronbach’s α=0.80 and cut-off scores are 5 (mild), 10
(moderate) and 15 (severe) [24].
Hospital Anxiety and Depression Scale
HADS is a 14-item scale (seven addressing anxiety (A) and seven for depression (D)), scored from 0 to 3 [25].
A score of 8 or more has been identified as the borderline cut-off point and 11+ indicates probable disorder.
Internal consistency for this measure is adequate to excellent with Cronbach’s α ranging between 0.68 and
0.93 for the HADS-A subscale and 0.67 to 0.90 for the HADS-D subscale [26].
Illness Perception Questionnaire-Revised
This questionnaire assesses peoples’ illness beliefs on nine dimensions: identity, cause, consequences, timeline
cyclical and chronic, personal and treatment control, emotional representations and illness coherence [27].
Identity is assessed by “yes” (1) or “no” (0) responses. Other dimensions are scored from 1 (“strongly disagree”)
to 5 (“strongly agree”). High total scores for identity, timeline, consequences and emotional representations
represent strong beliefs regarding number of symptoms attributed to the disorder, the chronic/cyclical nature of
the disorder, adverse consequences and negative emotional association, respectively. High control and
coherence scores indicate positive perceived controllability and good levels of understanding. Cronbach’s α was
0.75 for identity and 0.79 for all other subscales. This questionnaire was only relevant for cough patients.
Procedure
After consenting to take part, participants could complete the questionnaire pack at hospital or at home
(and return by post). Participants were also asked whether they would be happy to pass an adapted pack
on to a non-cough friend. For all questionnaires, participants responded by choosing the corresponding
scores or statements for each item.
The study received ethical approval from the NRES Committee North East – Tyne and Wear South.
Data handling and analysis
Missing data on an individual item level were handled by mean substitution within a subscale, in
accordance with advice given by each measure. On a subscale/questionnaire level, multiple imputation
(n=20) was undertaken, which acted as a sensitivity analysis.
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Multivariate analysis of variance (MANOVA) statistical analyses were conducted on the following
dependent variable groupings: 1) personality, 2) anxiety, depression, fatigue and somatic symptoms, and
3) illness representations. Univariate outputs were checked and/or multiple imputation data were consulted
in the case of a non-significant MANOVA result. This was to ensure that a non-significant difference
between groups at a multivariate level of analysis did indeed relate to non-significant differences between
groups on individual dependent variables, rather than being due to the lower sample size and subsequent
reduction in power, and therefore sensitivity, to detect an effect between groups at the multivariate level.
Where appropriate, analysis of variance (ANOVA) tests, t-tests and Tukey post hoc analyses were
conducted to ascertain differences between groups for individual dependent variables. To avoid type 1
error inflation, α levels were adjusted using Bonferroni adjustment. If results were non-significant at the
adjusted α level but were below the unadjusted level, they were still considered for further analyses, and
tentative conclusions were drawn.
Data checks were conducted on the original data set. Multivariate normality was judged to be adequate
through the use of standardised residual plots. Inter-variable correlations indicated there was no
multi-collinearity. Homogeneity of variance (univariate) was assessed by comparing group variances, and,
on the whole, these did not differ across the three groups. Statistics are reported accordingly, stated as equal
variances assumed or not assumed. Box’s M test assessed the multivariate homogeneity of covariance (this
test is highly sensitive so significance values would need to be highly significant to suggest heterogeneity,
which they were not). Leverage values were plotted to assess multivariate outliers and illustrated that none
were present.
Results
Participants
In total, 100 chronic cough and 72 non-cough packs were distributed. Response rates were 70% (n=67)
and 30.5% (n=22), respectively. The overall sample of 89 participants consisted of 25 CRC patients, 42
explained cough patients and 22 non-cough participants (see table 1 for sample demographics). Explained
cough diagnoses included asthma (38%), gastro-oesophageal reflux disease (14%), bronchiectasis, rhinitis,
angiotensin-converting enzyme inhibitor use, Sjögren’s associated interstitial lung disease, rheumatoid
arthritis, eosinphilic bronchitis, COPD, post-infectious cough, sleep apnoea, or a combination of these.
Details of current medications were not collected.
Personality
Using multivariate analyses, there was no statistically significant difference in the personality variables
based on participants’ cough grouping, F(10,156)=1.363, p=0.202; Wilks’ λ=0.846, partial ɳ2=0.080.
However, univariate analyses indicated there may be a difference between groups on the Neuroticism
dimension, F(2,82)=3.341, p=0.04; partial ɳ2=0.075 (adjusted α-level 0.01). Post hoc analyses showed that
refractory coughers reported higher Neuroticism scores than non-coughers (p=0.038), but this did not
reach significance at the adjusted α-level.
Anxiety, depression, fatigue and somatic symptoms
Multivariate analyses on the combination variable consisting of anxiety, depression, fatigue and somatic
symptoms indicated there was a statistically significant difference between cough groups; F(8,156)=3.384,
p=0.001; Wilks’ λ=0.726, partial ɳ2=0.148. Subsequent MANOVAs were conducted to analyse paired
group contrasts. There was a significant difference between refractory coughers and explained coughers,
F(4,59)=3.170, p=0.02; Wilks’ λ=0.823, partial ɳ2=0.177. There was a significant difference between
refractory coughers and non-coughers, F(4,40)=5.569, p=0.001; Wilks’ λ=0.642, partial ɳ2=0.358. There
was no significant difference between explained coughers and the non-cough group, F(4,54)=1.656,
p=0.174; Wilks’ λ=0.891, partial ɳ2=0.109; however, univariate analyses were still consulted to ensure a
potentially significant result was not missed.
TABLE 1 Participant demographics
Group
Refractory cough Explained cough Non-cough
Female n 19 24 18
Male n 6 18 4
Age years mean±SD 57.04±13.54 62.49±11.32 54.59±14.46
https://doi.org/10.1183/23120541.00099-2016 4
COUGH | K. HULME ET AL.
Univariate analyses were used to investigate the group differences for each of the four variables (adjusted
α=0.0125). These are presented in the following sections (see table 2 for mean and standard deviation
values).
Anxiety
Refractory coughers were more anxious than non-cough participants, F(1,43)=6.455, p=0.015, partial
ɳ2=0.131 (approaching significance at the adjusted α-level).
52% of refractory coughers displayed a clinical level of anxiety, the majority falling within the “moderate”
category (table 3). In comparison, 38% of explained coughers and 23% of non-coughers scored above the cut-off.
Depression
Refractory coughers were significantly more depressed than explained coughers, F(1,62)=10.287, p=0.002,
partial ɳ2=0.142, and non-cough participants, F(1,43)=15.321, p<0.001, partial ɳ2=0.263.
44% of refractory coughers recorded depression scores above the clinical cut-off, with 36% of the group
displaying mild levels of depression. In comparison, 14% and 9% of explained and non-coughers,
respectively, displayed mild levels of depression. None was moderately or severely depressed (table 3).
Fatigue
Refractory coughers were significantly more fatigued than explained coughers, F(1,62)=10.351, p=0.002,
partial ɳ2=0.143, as well as non-cough participants, F(1,43)=21.248, p<0.001, partial ɳ2=0.331 (figure 1).
Further consultation of the univariate result after multivariate analyses illustrated that explained coughers
were more fatigued than non-cough participants, F(1,57)=4.655, p=0.035, partial ɳ2=0.075, but this did
not reach significance at the adjusted α-level.
Somatic symptoms
Refractory coughers reported significantly more somatic symptoms than non-cough participants, F(1,43)=
13.663, p=0.001, partial ɳ2=0.241. Explained coughers also reported more somatic symptoms than non-cough
participants, F=(1,57), p=0.02, partial ɳ2=0.091, but this did not reach significance at the adjusted α-level.
Illness representations
Multivariate analyses indicated no significant difference between refractory and explained coughers
regarding their illness perceptions, F(8,38)=1.357, p=0.247; Wilks’ λ=0.778, partial ɳ2=0.222. However, the
majority of analyses after multiple imputation illustrated a significant difference (n=14), so univariate
TABLE 2 Descriptive statistics by group
Questionnaire Variable Group
Chronic
refractory cough
Explained cough Non-cough
Big Five Inventory Extraversion 3.11±0.87 3.51±0.73 3.39±0.70
Agreeableness 4.06±0.59 4.25±0.51 4.14±0.64
Conscientiousness 3.88±0.74 4.16±0.60 4.25±0.66
Neuroticism 3.11±1.06* 2.67±0.74 2.47±0.85
Openness 3.24±0.73 3.36±0.61 3.45±0.55
Hospital Anxiety and Depression Scale Anxiety 8.40±5.31* 6.76±3.97 4.91±3.74
Depression 6.56±4.12*# 3.88±2.78 2.55±2.74
Chalder Fatigue Scale Fatigue 19.96±6.69*# 15.48±5.68+ 12.50±5.24
Patient Health Questionnaire-15 Physical symptoms 10.48±6.02* 8.15±5.90+ 4.60±4.22
Illness Perception Questionnaire-Revised Identity 4.20±2.78 4.32±3.42
Timeline (chronic) 21.17±5.73 18.66±5.96
Consequences 18.83±5.32# 15.77±4.49
Personal control 16.79±5.32 17.95±3.83
Treatment control 16.00±3.87 17.66±3.02
Illness coherence 11.46±4.77# 14.62±4.75
Timeline (cyclical) 10.92±3.45 12.03±3.54
Emotional representations 18.42±5.27# 15.36±4.09
Data are presented as mean±SD. *: p<0.05 between CRC and non-cough; #: p<0.05 between CRC and explained cough; +: p<0.05 between
explained cough and non-cough.
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analyses were consulted. The individual significance values of illness coherence, consequences and
emotional representations were significant or approaching significance in the original data set and were all
significant in the majority of the multiple imputation data analyses.
Univariate paired contrasts were therefore conducted. These showed that refractory coughers held significantly
more negative consequence beliefs than explained coughers, t(61)=2.451, p=0.017, partial ɳ2=0.090. They also
associated significantly more negative emotions with their cough than explained coughers, t(61)=2.580,
p=0.012, partial ɳ2=0.098, and had significantly lower illness coherence in comparison to explained coughers,
t(61)=−2.557, p=0.013, partial ɳ2=0.097 (Bonferroni adjusted α=0.0167) (equal variances assumed).
Discussion
People with chronic cough in general reported higher levels of fatigue and somatic symptoms than
non-coughers. Refractory coughers specifically differed significantly from non-cough participants, reporting
higher levels of depression, anxiety, fatigue and somatic symptoms. In comparison to participants with
explained cough, refractory coughers scored significantly higher for fatigue and depression. Significant
differences between the two cough samples were also found for the illness representation dimensions:
consequences, illness coherence and emotional representations. Personality dimensions did not, at the most
rigorous level of analysis, differ between groups.
The mean anxiety score of refractory coughers (M=8.40) was slightly higher than those reported by
sufferers of conditions such as IBS (M=6.8 [28] and M=7.0 [29]). Given that members of the explained
cough group have received an underlying diagnosis, a significant difference in anxiety between the two
cough groups might be expected. This is what MCGARVEY et al. [5] reported when comparing state anxiety
in patients classified as idiopathic or treated cough. Although mean levels were higher in the CRC group
than in the explained cough group in the present study, this did not reach significance. The diagnoses of
the explained coughers could provide some explanation for this, as elevated anxiety is well recognised in,
for instance, COPD [30], asthma and bronchiectasis [31]. The high proportion of refractory coughers
displaying moderate levels of anxiety however, is in line with the conclusion of MCGARVEY et al. [5]
conclusion of increased levels of psychomorbidity within this patient population.
Depression did differ by cough group, and mean scores for refractory cough (M=6.56) were comparable or
higher than those reported in IBS studies (7.1 [28] and 3.9 [29]). Mean scores did not, however, reach
what are thought of as clinically significant levels (⩾8) [26]. The study by DICPINIGAITIS et al. [6] found that
FIGURE 1 Graph illustrating the
differences in fatigue across the
three groups. CRC: chronic
refractory cough; Ex: explained
cough. **: p=0.01; ***: p<0.001.
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TABLE 3 Anxiety and depression cut-off score frequencies by group
Cut-off values Anxiety Depression
Refractory cough# Explained cough¶ Non-cough+ Refractory cough# Explained cough¶ Non-cough+
0–7 12 (48%) 26 (62%) 17 (77%) 14 (56%) 36 (86%) 20 (91%)
8–10, mild 2 (8%) 8 (19%) 3 (14%) 9 (36%) 6 (14%) 2 (9%)
11–15, moderate 10 (40%) 6 (14%) 2 (9%) 1 (4%) 0 0
⩾16, severe 1 (4%) 2 (5%) 0 1 (4%) 0 0
#: n=25; ¶: n=42; +: n=22.
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over 50% of patients reported significant depressive symptomatology. Methodology may explain these
disparate findings. DICPINIGAITIS et al. [6] used the CES-D scale, which has one cut-off value and does not
distinguish mood severity, and the reported mean is at the lower end of their depressive symptomology
scale. As such, mood levels may be more similar than they appear and mild depression may be associated.
This conclusion is supported by the fact that 44% of the refractory cough sample displayed levels of
depression considered clinically significant, the majority scoring within the mild range.
Illness representations differed significantly between cough groups. Low illness coherence may highlight
the difficulty of managing an “unexplained” condition. FRANK [32] has pointed out the importance to
wellbeing of coherent narratives in chronic illness, and how chaos narratives (i.e. where individuals cannot
make sense of their symptoms) are associated with more distress. As KIRMAYER et al. [33] suggested in their
MUS studies, sense making is a transaction between the individual, publically available illness narratives
and health professionals. As such, failed coherence is a systemic problem rather than an individual fault. It
could be argued that increased anxiety and depression, perception of serious consequences and increased
emotional response may result from this lack of coherence around cough, although of course in a
cross-sectional study such causal links are speculative. We do know, however, that higher perceptions of
negative illness beliefs have been associated with worsened health outcomes in other conditions, such as
rheumatoid arthritis and psoriasis [34] and IBS [20, 21]).
Fatigue was significantly higher in CRC than in explained coughers. As a fatigue-specific measure has not
been used in cough populations before, reference to other conditions provides a useful indicator of clinical
significance. Levels of fatigue reported for CRC in this study (M=19.96) are below fatigue-based conditions
such as CFS (M=28 [35]). However, they are very similar to values reported in functional dysphonia
(M=17 [36]) and multiple sclerosis (20.94 [37]), the latter being a noteworthy comparison due to the
extent that fatigue is recognised as a prominent symptom and treatment target. This is a novel finding in
the CRC literature. The significant difference between the two cough groups warrants further investigation;
it suggests heightened fatigue in CRC may not be accounted for purely by the presence of cough. The
association between cough and sleep apnoea may be relevant here [38].
It must be noted, however, that rather than considering the involvement of such psychological factors with
CRC in isolation, it is likely that they interact, both with each other and with the cough symptoms over
time. Models of MUS have been proposed, such as the cognitive behavioural model of MUS [39], which
describe how psychological factors, including those in this study, may be involved. For example,
experiencing a cough but not being able to pinpoint the cause may result in reduced illness coherence and
increased distress (particularly in vulnerable individuals). Patients’ attention is then heightened to cough
sensations, modulating the urge to cough and increasing further coughing episodes. Extended neural
activation leads to sensitisation, reducing the cough threshold and further increasing the susceptibility of
an individual to experiencing cough symptoms. Although this is a hypothetical vicious cycle, a similar
framework with specific reference to cough has been described by VAN DEN BERGH et al. [40], providing a
much needed platform for further research in this area.
A strength of the study was the inclusion of three groups, allowing comparison between refractory and
explained coughers and a local “normal” non-cough group. Although relatively small, the sample sizes are
comparable to other studies in this area [5, 6], and appropriate statistical adjustments were made to
minimise possible power issues. Due to the cross-sectional study design, caution is advised when drawing
conclusions. A prospective study would provide further insight into the stability of the associations and
could identify predictor variables following a known trigger (i.e. respiratory infection). For example, a
similar study identified anxiety, negative illness beliefs and other somatic symptoms at the time of infection
as risk factors for IBS [29]. Similarly, a longitudinal study following coughers from first presentation,
i.e. pre-diagnosis, through to successful treatment (in the case of explained coughers) or no resolution (in
the case of unexplained coughers) would provide a more in-depth insight into the involvement and
interaction of psychological factors in different illness trajectories. This would also allow for data collection
at consistent and comparable points within the cough treatment period, for all cough patients. The
non-cough comparison group also warrants consideration. Accessing a comparison group of similar age
and socioeconomic status is difficult, so our group arose as a result of pragmatic sampling. We recognise
this is a limitation, as we do not know much about this group. We stipulated that they should not have a
chronic cough or were not attending hospital appointments, in an effort to create a “healthy” sample.
However, physical or psychological morbidity is something we could not fully control for in this instance.
In conclusion, CRC patients do differ significantly from both non-coughers and explained coughers on a
variety of psychological measures, identifying possible avenues for further research and intervention
targets. Training health professionals in how to help patients make sense of their symptoms may make
interventions more effective. This collaborative sense-making narrative work has shown promise in other
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persistent physical symptoms [41]. Low mood and fatigue management strategies are also warranted, given
the elevated level of both in this sample. Given that CRC is currently often poorly managed, targeting
factors such as those highlighted may help patients improve their management of the cough and reduce
the adverse impact it can have on their lives.
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